CIK 0001659617 · Non-accelerated filer<br>Smaller reporting company
Moleculin Biotech, Inc.
Sign in to watch- Ticker
- MBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474671997
- Phone
- 713-300-5160
- Business address
- 5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-20 | KLEMP WALTER V CEO and President | Option exercise | +3,750 | 62,046 | ||
| 2025-06-20 | KLEMP WALTER V CEO and President | Shares withheld for taxes | −914 | $0.27 | $244 | 61,132 |
| 2025-06-20 | KLEMP WALTER V CEO and President | Option exercise · Restricted Stock Units | −3,750 | 391,446 | ||
| 2025-06-20 | PICKER DONALD H Chief Science Officer | Option exercise | +1,078 | 9,079 | ||
| 2025-06-20 | PICKER DONALD H Chief Science Officer | Shares withheld for taxes | −263 | $0.27 | $70 | 8,816 |
| 2025-06-20 | PICKER DONALD H Chief Science Officer | Option exercise · Restricted Stock Units | −1,078 | 106,024 | ||
| 2025-06-16 | Foster Jonathan P. Chief Financial Officer | Option exercise | +833 | 12,196 | ||
| 2025-06-16 | Foster Jonathan P. Chief Financial Officer | Shares withheld for taxes | −203 | $0.69 | $139 | 11,993 |
| 2025-06-16 | Foster Jonathan P. Chief Financial Officer | Option exercise · Restricted Stock Units | −833 | 230,684 | ||
| 2025-06-16 | KLEMP WALTER V CEO and President | Option exercise | +1,667 | 58,702 | ||
| 2025-06-16 | KLEMP WALTER V CEO and President | Shares withheld for taxes | −406 | $0.69 | $278 | 58,296 |
| 2025-06-16 | KLEMP WALTER V CEO and President | Option exercise · Restricted Stock Units | −1,667 | 370,075 | ||
| 2024-11-04 | Yan Joy Director | Grant or award · Stock option (right to buy) | +10,000 | 14,001 | ||
| 2024-11-04 | Cermak Elizabeth Director | Grant or award · Stock option (right to buy) | +10,000 | 14,668 | ||
| 2024-11-04 | Climaco John M Director | Grant or award · Stock option (right to buy) | +10,000 | 15,169 | ||
| 2024-11-04 | George Robert E. Director | Grant or award · Stock option (right to buy) | +10,000 | 15,336 | ||
| 2024-11-04 | CANNON MICHAEL D Director | Grant or award · Stock option (right to buy) | +10,000 | 15,336 | ||
| 2024-11-04 | PICKER DONALD H Chief Science Officer | Grant or award · Stock option (right to buy) | +40,000 | 66,358 | ||
| 2024-11-04 | PICKER DONALD H Chief Science Officer | Grant or award · Restricted Stock Units | +35,000 | 101,358 | ||
| 2024-11-04 | Foster Jonathan P. Chief Financial Officer | Grant or award · Stock option (right to buy) | +65,000 | 129,837 |
Page 5 of 12 · 236 trades